Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50000 participants
OBSERVATIONAL
2000-01-31
2010-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Renal Denervation in Chronic Kidney Disease - RDN-CKD Study
NCT04264403
Inflammation and Nutritional Parameters in Hemodialysis Patients Using Reprocessed Dialyzers
NCT00440908
Arterial Calcifications in Nocturnal Hemodialysis and Renal Transplantation Versus Conventional Dialysis
NCT00950573
Comparison of Daily Nocturnal Hemodialysis With Daily Hemodialysis
NCT00012441
Coupling Between Clotting Characteristics in Chronic Hemodialysis Patients and the Hemodialyzer Patency
NCT05440201
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hemodialysis patients
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
88 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fresenius Medical Care North America
INDUSTRY
Maastricht University
OTHER
University of California
OTHER
Medical University Innsbruck
OTHER
Renal Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Renal Research Institute
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter Kotanko, MD
Role: PRINCIPAL_INVESTIGATOR
Renal Research Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Renal Research Institute
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10-119
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.